Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Seizure Prophylaxis in Brain Tumor Patients Undergoing Neurosurgical Procedure

NCT03436433 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03436433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03436433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Seizure Prophylaxis in Brain Tumor Patients Undergoing Neurosurgical Procedure
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2019
Completion date
December 4, 2020
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, glioma, glioma of brain